21-Oct-2021
Neuren receives feedback on IND for Phelan-McDermid syndrome Neuren receives feedback on IND for Phelan-McDermid syndrome

20-Oct-2021
Change of Director's Interest Notice - D Angus Change of Director's Interest Notice - D Angus

11-Oct-2021
US patent to 2034 granted for Neuren's NNZ-2591 in autism US patent to 2034 granted for Neuren's NNZ-2591 in autism

8-Oct-2021
Change of Director's Interest Notice - J Harry Change of Director's Interest Notice - J Harry

8-Oct-2021
Change of Director's Interest Notice - J Pilcher Change of Director's Interest Notice - J Pilcher

8-Oct-2021
Change of Director's Interest Notice - P Davies Change of Director's Interest Notice - P Davies

8-Oct-2021
Application for quotation of securities - NEU Application for quotation of securities - NEU

6-Oct-2021
Update - Proposed issue of securities - NEU Update - Proposed issue of securities - NEU

6-Oct-2021
$3.3 million raised from oversubscribed SPP $3.3 million raised from oversubscribed SPP

1-Oct-2021
Feedback on Angelman IND and submission of Pitt Hopkins IND Feedback on Angelman IND and submission of Pitt Hopkins IND